2:59 PM
Nov 14, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Liver cancer

Patient sample and mouse studies suggest depleting IgA-positive plasma cells in the liver could help treat non-alcoholic steatohepatitis (NASH)-induced hepatocellular carcinoma (HCC). In liver samples from 18 NASH patients, IgA levels were associated with fibrosis, a risk marker for progression to HCC. In...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >